Dmitriy Dmitrievich Genkin

Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel.

SANTERSUS AG is a Swiss therapeutic apheresis company that focuses on cleansing patient blood through the selective extra corporeal removal of neutrophil extracellular traps (NETs). The private company is located in Switzerland. NETs are fibers produced by neutrophils, which are the largest fraction of white blood cells produced by the bone marrow. The company is developing a novel patent-protected transformative, lifesaving, blood purification device for use in the treatment of sepsis, autoimmune diseases, cancer, and COVID-19.

SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation.

Part of Pharmsynthez PJSC, Kevelt AS is an Estonian company that manufactures and distributes pharmaceutical products. The private company is based in Tallinn, Estonia. Kevelt was acquired by Pharmsynthez PJSC on January 17, 2011.

FDS Pharma LLP manufactures pharmaceutical products. The company was founded on March 28, 1996 and is headquartered in London, the United Kingdom.

Part of Firebird Management Partners LP, EPhaG AS is a holding Estonian company for pharmacies. The private company is based in Viimsi Harjumaa, Estonia.